Logomasini Mark 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Jun 11, 2010
Insider Transaction Report
Form 4
Logomasini Mark
Director
Transactions
- Award
Option (Right-to-buy)
2010-06-10$0.15/sh+45,000$6,750→ 45,000 totalExercise: $0.15Exp: 2017-06-09→ BJCT Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Vesting schedule: 25% on 6/10/11, 25% on 6/10/12, 25% on 6/10/13 and 25% on 6/10/14